British Oncology brings the world's most advanced breast cancer treatment to the region for the first time — GammaPod® Stereotactic Breast Radiosurgery, delivering extraordinary precision in just 1 to 3 treatment sessions.
Conventional breast radiotherapy requires 25–30 daily sessions over 5–6 weeks. GammaPod delivers the full therapeutic dose in just 1 to 3 comfortable sessions — transforming the treatment journey for patients who often cannot take weeks away from family and work.
GammaPod's unique prone positioning and precision delivery means radiation never reaches the skin surface. Patients experience no skin redness, irritation or burns — one of the most distressing side effects of conventional radiotherapy, now completely eliminated.
Left-sided breast cancer treatments using conventional techniques carry a well-documented risk of long-term cardiac damage. GammaPod's sub-millimetre precision and prone positioning dramatically reduce heart and lung radiation — protecting long-term health after treatment.
GammaPod uses a liquid-filled breast immobilisation cup and real-time image guidance to deliver radiation with sub-millimetre accuracy — targeting only the tumour volume while leaving surrounding healthy breast tissue entirely untouched.
Patients lie face-down on the GammaPod table, with the breast suspended naturally through an opening. This prone position naturally moves the breast away from the chest wall — increasing the distance between the tumour and the heart and lungs still further.
British Oncology will be the first centre in the Middle East, GCC and Africa to offer GammaPod Stereotactic Breast Radiosurgery — bringing a treatment previously available only in the USA and Europe to patients across the Gulf, MENA and Sub-Saharan Africa.
British Oncology's Women's Cancer Centre offers the complete breast cancer pathway — from early detection through to treatment and follow-up care, all delivered in one compassionate, expert environment.
Dedicated breast cancer screening clinics. Early detection programme with mammography, ultrasound and MRI. Specialist referral from across the region.
PET-CT nuclear medicine for precise staging. Multidisciplinary tumour board review. Expert biopsy and pathology services.
1–3 GammaPod sessions. Sub-millimetre precision. Zero skin dose. Minimal heart & lung exposure. Day-patient procedure.
Ongoing monitoring and follow-up imaging. Survivorship programme. International patient coordination for remote follow-up.
For women across the Middle East, GCC and Africa, accessing advanced breast cancer treatment has meant long journeys to Europe or North America — weeks away from family, culture, and support networks.
British Oncology changes this. Our Women's Cancer Centre is designed with the cultural sensitivity, linguistic diversity and clinical excellence that women in our region deserve — in Dubai, within reach of home.
British Oncology's GammaPod Centre is the first dedicated breast cancer radiosurgery facility in the Middle East — designed specifically to bring NHS-standard care to patients across the Gulf, MENA and Africa.